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ABSTRACT
The aim of the work presented here was to
determine the role of dry powder inhaler (DPI)
counselling on inhalation technique and lung
function test scores of the asthmatic patients.
To decrease variability, asthmatic patients using
an Aerolizer were enrolled in the study, as this
was the most commonly prescribed DPI in
outpatient clinics of Beni Suef University
hospital. Each patient was subjected to three
visits separated by 1 month each. In each visit,
patient inhalation technique from the DPI was
checked, and the number of mistakes was
identified and corrected. Also, patients’ peak
expiratory flow (PEF) and forced expiratory
volume in one second (FEV1) presented as a
percentage of the forced vital capacity (FVC)
were checked. As the number of visits increased,
the mean number of observed mistakes was
significantly decreased (p\0.001). The most
common repeated mistakes were ‘‘To inhale
fast’’ and ‘‘To maintain a fast inhalation rate
until the lungs are full’’. In all age groups, there
was a significant increase (p\0.001) in the
pulmonary function test after the period of
counselling. To improve and maintain the
recommended inhalation technique of DPI
and possibly improve patients’ lung function
test scores, counselling on proper DPI technique
should be repeated at every possible
opportunity.
Keywords: Aerolizer; Asthma; Counselling; Dry
powder inhaler; FEV1; Number of mistakes; PEF
INTRODUCTION
Inhalers are the most common type of
medication devices used to treat obstructive
lung diseases. However, they are often not
properly used, leading to uncontrolled disease
and increased costs [1]. This remains a common
problem in obstructive lung diseases [2–4]. A
M. O. Elgendy
Hospital Pharmacy Department, Teaching Hospital
of Faculty of Medicine, Beni Suef University, Beni
Suef, Egypt
M. E. Abdelrahim (&)
Clinical Pharmacy Department, Faculty of
Pharmacy, Beni Suef University, Beni Suef, Egypt
e-mail: Mohamed.abdelrahim@pharm.bsu.edu.eg
R. S. Eldin
Respiratory Department, Faculty of Medicine, Beni
Suef University, Beni Suef, Egypt
Pulm Ther (2015) 1:91–101
DOI 10.1007/s41030-015-0004-9
call for action to the medical community
recently published in the European Respiratory
Journal explained how training in proper
technique might be of practical importance
[5]. The worldwide costs associated with the
management of asthma and chronic obstructive
pulmonary disease (COPD) in adults and
children are very large, from both the
healthcare payer and the societal points of
view [6–10]. In a more than 10-year-old review
of 21 studies looking at misuse of inhalers, poor
technique was estimated to be prevalent in
14–90 % (with an average of 50 %) of cases [11].
This level of misuse is still presented in recent
studies [4, 12–17]. However, the same studies
showed that a substantial increase in correct use
occurred after training [4, 12–17]. Further
improvement in correct use as well as lung
function occurred with repeated counseling [4].
Poor inhalation technique may force the
prescriber to step up treatment to control
asthma. Hence, there is tremendous potential
for improved inhalation technique to improve
asthma control and reduce prescription costs.
For this reason, the aim of the present work
was to study the effect of repeated counselling
on inhalation technique for DPIs, as one of the
most important devices in the treatment of
obstructive lung diseases, for the asthmatic
patients and its possible effect on the lung
function test scores.
METHODS
Because each device has its own method of
administration, we tried to decrease the number
of variables by choosing one type of DPI that
was most commonly prescribed to patients in
Beni Suef University hospital outpatient clinics.
By asking chest healthcare providers in
outpatient clinics, it was found that Aerolizer
[Foradil (formoterol) and Miflonide
(budesonide); Novartis, Egypt] was the most
commonly prescribed DPI there. In this study, a
number of asthmatic subjects using an Aerolizer
DPI were collected from Beni Suef University
hospital outpatient clinics throughout a 2-year
period (from May 2013 to May 2015). To
overcome the need for inclusion of a control
group in the study, we chose patients that had
been using, and were still using, an Aerolizer for
at least 3 months prior to taking part in the
study. Hence, patient results at the start of the
study can be used as a baseline. An ethical
approval was obtained from the University of
Beni Suef for the study. All procedures followed
were in accordance with the ethical standards of
the responsible committee on human
experimentation (institutional and national)
and with the Helsinki Declaration of 1964, as
revised in 2013. Informed consent was obtained
from all patients for being included in the
study.
Each patient was subjected to three visits
separated by 1 month each. In each visit all the
subjects were asked to show the investigator
how they use their DPI. Investigator then
detected and corrected the mistakes with the
correct steps listed below. DPI inhalation
technique was divided into steps as it was
previously shown that the division could make
the counselling more effective and enable
investigator to detect the weaker steps [18–20].
The Correct Method of Using DPI
Step 1. Remove the protective cap from
mouthpiece of the DPI.
Step 2. Prepare the DPI dose as instructed in
the patient pamphlet.
Step 3. Breathe out as far as comfortable.
Step 4. Place the DPI mouthpiece between
the teeth and seal with lips.
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Step 5. Ensure your tongue does not obstruct
the mouthpiece.
Step 6. Inhale as fast and deep as possible.
Step 7. Maintain a fast inhalation rate until
the lungs are full.
Step 8. Remove the DPI from the mouth and
hold breath for 5–10 s.
Step 9. If more than one dose each time, wait
about 30 s before the next dose.
Step 10. Rinse mouth, and if possible brush
teeth after dosing.
Step 11. Replace cap on the DPI.
Each subject in each visit was asked to perform a
pulmonary function test (PFT) using a handheld
spirometer (One-Flow FVC Kit, Clement Clarke,
UK) for measuring lung function. The outcome
data were peak expiratory flow (PEF) in L/min
and forced expiratory volume in 1 s (FEV1) as
percentage of the forced vital capacity (FVC).
Included subjects in the study were
asthmatic subjects with an Aerolizer as
prescribed inhaler to control their asthma and
able to perform pulmonary function test
correct. The patients started using the
Aerolizer at least 3 months prior inclusion in
the study. Thus, their first visit can be used as
their own control.
Statistical Analysis
The analysis was made by Friedman test
followed by Wilcoxon test for the comparison
between the main variables and within-group
comparison of PEF and FEV1/FVC percentage,
and for mean number of mistakes of each visit.
Cochran test followed by McNemar test was
used for the comparison between the results of
total number of mistakes at each step of each
visit.
The effect of age categories on DPI results
(PEF and FEV1/FVC percentage and for mean
number of mistakes of each visit) was analysed
using two-way analysis of variance (ANOVA)
test at p\0.05 followed by post hoc using
Tukey system.
RESULTS
A number of 310 (164 female) asthmatic
patients, with mean (SD, range) age 48.7 (13.1,
20–78) years old completed the study. Their
results were studied as one whole group of
patients and divided into three groups
according to their age.
GP1 (\40 years old) was 89 (52 female)
patients; GP2 (40–60 years old) was 160 (83
female) patients and GP3 ([60 years old) was 61
(29 female) patients.
There was no significant difference in all the
tested parameters between male and female in
all age groups. The mean (SD) of PEF, FEV1/
FVC%, and the number of mistakes are
presented Table 1 and Fig. 1. PEF in GP3 was
significantly lower than that of GP2 (p = 0.05).
FEV1/FVC% in GP3 was significantly lower than
those of GP2 and GP1 (p = 0.001). There was no
significant difference in number of mistakes
between the three age groups in the three visits.
The number of mistakes of each step in the
three visits is presented in Table 2 and Fig. 2.
Some steps showed no mistakes at all, and some
showed mistakes that improved with
counselling. Within each of those steps, there
was a significant (p\0.001) decrease in the
number of mistake in the 2nd visit than the 1st
visit, followed by a significant (p\0.001)
decrease in the number of mistake in the 3rd
visit. The only insignificant difference between
two visits was between 2nd and 1st visits in step
9 ‘‘If more than one dose each time, wait about
30 s before the next dose’’ and between 2nd and
3st visits in steps 4 ‘‘Place the DPI mouthpiece
between the teeth and seal with lips’’ and 8
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‘‘Remove the DPI from the mouth and hold
breath for 5–10 s’’ with a high number of
mistakes in the 2nd visit. Percentage of correct
steps of the three age categories in each visit is
presented in Fig. 3. All the steps had comparable
results in the three age categories.
DISCUSSION
It was previously shown that increasing patient
knowledge about self-management by
counselling can improve their adherence to
the medications [21–24].
The present study permitted us to analyze
the difficulties that these patients might have
when using their DPI. Similar to previous
studies, the results showed that most of the
patients using a DPI did not perform correct
inhalation technique in the 1st visit, but they
significantly improved in the 2nd (p\0.001)
[17, 25–27] and improved further in the 3rd
visits (p\0.001) [4]. Hence, repetition of the
instructions can be significantly correlated with
correct inhalation technique (p\0.001) [4, 28].
The high number of errors observed at the 1st
visit may lead to insufficient drug delivery,
adversely influence drug efficacy, and may
contribute to inadequate control of asthma
[25]. That was observed in the low PEF and
FEV1/FVC% in the 1st visit.
The steps with the highest number of
mistakes were steps 6 and 7. Patients did not
know that they had to inhale as fast and deep as
possible from the DPI [13]. Also, it was very
difficult to teach the patients to maintain a fast
inhalation rate until the lungs were full. In the
2nd visit, patients improved slowly in the
overall results of steps 6 and 7 compared to
other steps. However, they showed much better
improvement in the 3rd visit. With DPIs, the
Table 1 Mean (SD) PEF, FEV1/FVC%, and number of mistakes in each visit
1st visit 2nd visit 3rd visit Overall p value
PEF GP1 (L/min)*,# 74.8 (27.7) 82 (25.0) 76.7 (24.0) \0.05
PEF GP2 (L/min)9 79.5 (31.0) 78.8 (23.2) 88.2 (32.0) \0.001
PEF GP3 (L/min)*,# 69.5 (28.9) 76.6 (25.8) 79.8 (36.2) \0.05
PEF overall (L/min) 76.2 (29.8) 79.3 (24.2) 83.3 (31.2) \0.001
FEV1/FVC GP1 (%)
9 77.5 (15.2) 81.0 (13.4) 85.9 (13.5) \0.001
FEV1/FVC GP2 (%)
9 76.4 (16.1) 78.5 (13.9) 86.0 (12.7) \0.001
FEV1/FVC GP3 (%)
9 70.5 (18.0) 74.7 (14.9) 81.3 (16.2) \0.001
FEV1/FVC overall (%) 75.5 (16.4) 78.5 (14) 85.0 (13.8) \0.001
Number of mistakes GP1** 4.0 (1.2) 2.9 (1.1) 1.9 (1.1) \0.001
Number of mistakes GP2** 3.9 (1.0) 3.0 (1.0) 1.6 (1.1) \0.001
Number of mistakes GP3 ** 3.8 (1.2) 2.8 (1.0) 2.1 (1.0) \0.001
Number of mistakes overall 3.9 (1.1) 2.9 (1.0) 2.0 (1.1) \0.001
NS no signiﬁcant difference
9 No signiﬁcant difference between 1st and 2nd visits
# No signiﬁcant difference between 2nd and 3rd visits
*p value between 1st and 2nd visits\0.05, **p value between 1st and 2nd visits\0.001
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fine particle fraction and, consequently, lung
deposition are dependent on inspiratory flow
rate achieved by the patient [29–31]. That is
affected mainly by steps 6 and 7. Thus, before
prescribing a DPI, the patient should be checked
for the ability to inhale deeply and forcibly for
good lung drug deposition [25, 32]. The 3rd visit
improvement in steps 6 and 7 support the
recommendation that inhalers need reinforced
counselling at every opportunity [4] as patients
may forget or be uncertain of how to inhale fast
and how to maintain a fast inhalation flow.
Fig. 1 a Mean (SD) PEF in each age group and the whole results together. b Mean (SD) FEV1/FVC% in each age group
and the whole results together. c Mean (SD) number of mistakes in each age group and the whole results together
Fig. 2 Number of mistakes of each visit in each step
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Some training devices can be used such as the
In-Check Dial to help patients obtain the most
desirable inhalation rate when using a DPI [33,
34]. The patient information leaflet provided
with this training aid encourages patients to
practice using the device in the same way that
they would use their DPI [35].
The numbers of correct steps were improved
by counselling in all age groups by going further
in visits. Step 8 ‘‘Remove theDPI from themouth
and hold breath for 5–10 s’’, showed also slow
improvement, but not as slow as steps 6 and 7.
Therefore, when counselling patients,more time
should be given to those three steps tomake sure
they understandhow to do themproperly. Those
three steps were believed to be related to patient
technique and not related to the type of DPI [13].
Therefore, reinforcement of their correct
technique at every opportunity can improve
the inhalation technique of any DPI.
Steps 3 ‘‘Breathe out as far as comfortable’’, 4
‘‘Place the DPI mouthpiece between the teeth
and seal with lips’’, 9 ‘‘If more than one dose
each time, wait about 30 s before the next
dose’’, 10 ‘‘Rinse mouth, and if possible brush
teeth after dosing’’, and 11 ‘‘Replace cap on the
DPI’’ had a much higher significant
improvement in the 2nd visit (p\0.001)
compared to steps 6, 7, and 8. Hence, they
could be much easier to be remembered when
taught well.
An insignificant number of patients during
step 3, ‘‘Breathe out as far as comfortable’’,
exhaled through the mouthpiece of the DPI.
That can cause a humidity increase within the
DPI, which might cause variance in delivered
dose [36, 37].
Some steps, step 1 ‘‘Remove the protective
cap from mouthpiece of the DPI’’, step 2
‘‘‘Prepare the DPI dose as instructed in the
Fig. 3 Percentage of correct steps of the four age categories in each visit a\40 years old, b 40–60 years old, and c[60 years
old 40 years old, b[40–60 years old and c[60 years old
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patient pamphlet’’, and step 5 ‘‘Ensure your
tongue does not obstruct the mouthpiece’’,
showed no mistakes in the three visits. These
steps were spontaneously done during routine
use of the DPI.
There was no significant difference between
the three age groups in the mean number of
mistakes. However, the change in mean number
of mistakes between the 3rd and 1st visits was
highest, but with no significant difference in
GP2 (40–60 years old), who might be more keen
to learn how to control their asthma compared
to the other groups. Also, it was found that most
of the older adult DPI users had more
experience in using a DPI than the younger
users. This was observed in the slightly higher
mean number of mistakes at the 1st visit in GP1
(young group) followed by no significant
difference in 2nd and 3rd visits.
GP3 was the group with least improvement
after the 3rd visit. That might be due to their
theoretical believes that they were already
doing the correct inhalation technique or due
to learning capacity and memory factors [22].
The learning capacity problem was obvious in
step 4, ‘‘Place the DPI mouthpiece between the
teeth and seal with lips’’ In GP3 (very old
patients); no significant difference was found
between the 2nd and the 3rd visits in the total
number of mistakes for step 4. It was very
difficult for GP3 (very old patients) to remember
to place the DPI mouthpiece between the teeth
not only between lips.
From the resulting number of mistakes, we
can recommend the DPI as a very easy method
of delivering medication for asthmatic patients
with one condition, which is continuous
counselling [36]. Also, the ability to use
Table 2 The overall number of mistakes of each step in the three visits
Step number and details 1st visit 2nd visit 3rd visit p value
1. Remove the protective cap from mouthpiece of the DPI – – – NS
2. Prepare the DPI dose as instructed in the patient pamphlet – – – NS
3. Breathe out as far as comfortable 121 64 33 \0.001
4. Place the DPI mouthpiece between the teeth and seal with lips# 126 76 65 \0.001
5. Ensure your tongue does not obstruct the mouthpiece – – – NS
6. Inhale as fast and deep as possible 260 227 158 \0.001
7. Maintain a fast inhalation rate until the lungs are full 260 225 158 \0.001
8. Remove the DPI from the mouth and hold breath for 5–10 s# 220 139 123 \0.001
9. If more than one dose each time, wait about 30 s before the next dose* 52 66 18 \0.001
10. Rinse mouth, and if possible brush teeth after dosing 142 80 53 \0.001
11. Replace cap on the DPI 25 13 0 NS
Total number of mistakes 1206 890 608 \0.001
NS no signiﬁcant difference
* No signiﬁcant difference between 1st and 2nd visits
# No signiﬁcant difference between 3rd and 2nd visit
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correctly an inhaler can be positively correlated
with counselling, age, and experience.
However, two previous studies had shown
that there was no effect of age or education [13,
25]. This different result can be attributed to the
patients they studied, as they were all newly
diagnosed patients who might have less DPI
experience.
A higher inspiratory flow is required to
operate a DPI, meaning that it may not be
appropriate for patients with very severe asthma
[38] or very old patients, e.g., GP3 [25]. They
need to use a DPI with low resistance or inhale
twice from their DPI [30]. However, this was not
observed in the present study as the Aerolizer is
a DPI with very low resistance that allows most
asthmatic patients to receive the inhaled dose
easily.
When looking at the pulmonary function
test (PFT) results, it was found that there were
improvements in the patients’ PEF and FEV1/
FVC%. However, the improvement in PFTs was
slower than in the number of mistakes. The
comparison between the 1st and 2nd visits in
the PEF and the FEV1/FVC% showed no
significant improvement, but the
improvement was significant at the 3rd visit
(p\0.001). Similarly, asthmatics and COPD
patients receiving education showed a
significant increase (p\0.001) in PEF, FEV1 ,
and FVC values over a final month of follow-up
[15, 17, 39, 40].
Repeated counselling showed a beneficial
effect on pulmonary function tests in all age
groups, especially in GP3 ([60 years old). This
group of patients may need continuous
counselling and follow-up due to expected
age-related memory problems with cognitive
decline and poor vision. These factors might led
to inhaler misuse [22].
The effects of Aerolizer counselling on PEF,
FEV1/FVC% were similar to our previously
published effects of MDI counselling [4]. This
was expected, as the improvement in
pulmonary function tests with patient
adherence to treatment and correct use of
their inhaler, either DPI or MDI, should
improve the patients’ PFTs regardless the type
of the device they use [1, 15–17].
However, the total number of mistakes
when using an MDI was much higher than
with a DPI for all groups in all visits. This
could mean that even though the counselling
has an improving effect on both DPI and MDI
inhalation technique, the DPI was still much
easier than the MDI. That may be due to
coordination needed when using the MDI or
cold freon effect that occurs with the MDI [25,
27].
These cumulative clinical improvement
results supports the importance of the recent
call for action published in the European
Respiratory Society Journal [5], which
emphasized the importance of correct inhaler
choice, proper training, and ongoing education
to maintain technique qualities.
CONCLUSION
Inhalation technique should be checked and
reinforced at regular intervals, especially for
very old patients who might have greater
difficulty in perfectly using a DPI. Continuous
counselling could result in improvement in the
quality of life of the patients by improving their
lung function. Critical errors in DPI inhalation
technique, e.g., not inhaling fast and
maintaining fast inhalation, must be avoided
and taught well to the patient.
The limitation of the present study was the
large number of DPIs with different methods of
dose preparation and airflow resistance that
makes it very hard to include in one study.
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Hence, we recommend more counselling
studies using different types of DPI, with and
without the introduction of training aid
devices.
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